LON:ONC - Oncimmune Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Oncimmune Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 37.50 0.00 (0.00 %) (As of 01/28/2020 04:00 PM ET) Add Compare Today's Range 37Now: GBX 37.50▼ 37.6550-Day Range 37MA: GBX 39.04▼ 4652-Week Range 36Now: GBX 37.50▼ 115Volume43,000 shsAverage Volume33,554 shsMarket Capitalization£23.72 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Oncimmune Holdings Plc, an early cancer detection company, develops and commercializes products to diagnose cancer in the United Kingdom and North America. The company engages in the development of autoantibody based platform to allow cancer detection to a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test, which is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company also develops EarlyCDT-Liver to aid in the detection and confirmation of hepatocellular carcinoma (HCC) in high-risk patients with liver lesions of all sizes tests for liver cancer. Oncimmune Holdings Plc was incorporated in 2015 and is headquartered in Nottingham, the United Kingdom. Industry, Sector and Symbol Stock Exchange LON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:ONC Previous Symbol CUSIPN/A CIKN/A Webhttp://oncimmune.com/ Phone+44-115-8231869Debt Debt-to-Equity RatioN/A Current Ratio5.66 Quick Ratio5.36Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£171,000.00 Price / Sales138.71 Cash FlowGBX 8.50 per share Price / Cash Flow4.41 Book ValueGBX 12.40 per share Price / Book3.02Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees52 Outstanding Shares63,250,200Market Cap£23.72 million Next Earnings Date2/11/2020 (Estimated) OptionableNot Optionable Receive ONC News and Ratings via Email Sign-up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. LSE:ONC Rates by TradingView Oncimmune (LON:ONC) Frequently Asked Questions What is Oncimmune's stock symbol? Oncimmune trades on the London Stock Exchange (LON) under the ticker symbol "ONC." How were Oncimmune's earnings last quarter? Oncimmune Holdings PLC (LON:ONC) issued its quarterly earnings results on Tuesday, February, 13th. The company reported ($5.70) earnings per share (EPS) for the quarter. The business earned $0.08 million during the quarter. View Oncimmune's Earnings History. When is Oncimmune's next earnings date? Oncimmune is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Oncimmune. What price target have analysts set for ONC? 0 analysts have issued 1-year target prices for Oncimmune's stock. Their forecasts range from GBX 150 to GBX 150. On average, they expect Oncimmune's stock price to reach GBX 150 in the next year. This suggests a possible upside of 300.0% from the stock's current price. View Analyst Price Targets for Oncimmune. Has Oncimmune been receiving favorable news coverage? Press coverage about ONC stock has trended somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Oncimmune earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the near term. View News Stories for Oncimmune. Who are some of Oncimmune's key competitors? Some companies that are related to Oncimmune include Yourgene Health (YGEN), Lexagene (LXG), BARD1 Life Sciences (BD1), Sernova (SVA), GeneNews (GEN), SQI Diagnostics (SQD), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), Dorsavi (DVL), Cambridge Cognition (COG), Genedrive (GDR), VentriPoint Diagnostics (VPT), Smiles Inclusive (SIL) and Lifespot Health (LSH). What other stocks do shareholders of Oncimmune own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oncimmune investors own include Digi International (DGII), SeaChange International (SEAC), SMTC (SMTX), Actinium Pharmaceuticals (ATNM), Axsome Therapeutics (AXSM), Chimerix (CMRX), Constellation Pharmaceuticals (CNST), Correvio Pharma (CORV), Groupon (GRPN) and Iclick Interactive Asia Group (ICLK). Who are Oncimmune's key executives? Oncimmune's management team includes the folowing people: Dr. Adam Mark Hill Ph.D., CEO & Director (Age 39)Mr. Andrew Millet BA, FCA, MBA, Exec. (Age 52)Mr. Matthew Hall, Group Chief Financial OfficerDr. Laura J. Peek, Principal Scientist & Assistant Lab DirectorMr. Andrew Stewart, Gen. Counsel & Company Sec. How do I buy shares of Oncimmune? Shares of ONC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Oncimmune's stock price today? One share of ONC stock can currently be purchased for approximately GBX 37.50. How big of a company is Oncimmune? Oncimmune has a market capitalization of £23.72 million and generates £171,000.00 in revenue each year. Oncimmune employs 52 workers across the globe.View Additional Information About Oncimmune. What is Oncimmune's official website? The official website for Oncimmune is http://oncimmune.com/. How can I contact Oncimmune? Oncimmune's mailing address is Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231869. MarketBeat Community Rating for Oncimmune (LON ONC)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 65 (Vote Outperform)Underperform Votes: 86 (Vote Underperform)Total Votes: 151MarketBeat's community ratings are surveys of what our community members think about Oncimmune and other stocks. Vote "Outperform" if you believe ONC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ONC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/28/2020 by MarketBeat.com StaffFeatured Article: How is the LIBOR rate calculated?
